UK tissue products manufacturer Accrol Group continued to grow both sales revenues and Ebitda in the 2022/2023 financial year that ended 30 April. New sales channels, changes in consumer behaviour, measures to increase efficiency and a broad base of retail partners contributed to this positive development, the compa...
Read more
You can only use this article with a valid subscription and registration. Registered subscribers can access all articles after entering their user name and password.
- Ad -